Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis

Biomarker research across the health-to-disease continuum is being increasingly applied. We applied blood-based metabolomics in order to identify patient clusters with a first demyelinating episode, and explored the prognostic potential of the method by thoroughly characterizing each cluster in term...

Descripción completa

Detalles Bibliográficos
Autores principales: Boziki, Marina, Pechlivanis, Alexandros, Virgiliou, Christina, Bakirtzis, Christos, Sintila, Styliani Aggeliki, Karafoulidou, Eleni, Kesidou, Evangelia, Theotokis, Paschalis, Nikolaidis, Ioannis, Theodoridis, Georgios, Gika, Helen, Grigoriadis, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735785/
https://www.ncbi.nlm.nih.gov/pubmed/36498904
http://dx.doi.org/10.3390/ijms232314578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735785/
https://www.ncbi.nlm.nih.gov/pubmed/36498904
http://dx.doi.org/10.3390/ijms232314578

Ejemplares similares